We are live on
!
Find out more
CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+5.39%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.1B
AUM Growth
-$138M
(-6.2%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-10.1%
Top 10 Holdings %
Top 10 Hldgs %
28.75%
Holding
831
New
19
Increased
68
Reduced
304
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$5.28M |
| 2 |
iShares MSCI Canada ETF
EWC
|
+$4.61M |
| 3 |
CVS Health
CVS
|
+$4.24M |
| 4 |
Aptiv
APTV
|
+$3.61M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$3.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$47.4M |
| 2 |
Union Pacific
UNP
|
+$31.8M |
| 3 |
UnitedHealth
UNH
|
+$21.1M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$12.8M |
| 5 |
Visa
V
|
+$11.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Financials | 14.51% |
| 3 | Healthcare | 13.47% |
| 4 | Miscellaneous | 13.36% |
| 5 | Consumer Discretionary | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cigna
CI
$73.7B
| $151K | 0.01% |
591
| – | – |
|
302
CrowdStrike
CRWD
$224B
| $151K | 0.01% |
4,400
+2,200
| +100% | +$63.6K |
|
303
Roper Technologies
ROP
$42.2B
| $151K | 0.01% |
342
-40
| -10% | -$17.3K |
|
304
T. Rowe Price
TROW
$23.7B
| $149K | 0.01% |
1,320
| – | – |
|
305
DTE Energy
DTE
$28.3B
| $149K | 0.01% |
1,360
| – | – |
|
306
iShares Russell 2000 Value ETF
IWN
$14.5B
| $149K | 0.01% |
1,085
-864
| -44% | -$125K |
|
307
Enterprise Products Partners
EPD
$84.3B
| $149K | 0.01% |
5,736
| – | – |
|
308
Microchip Technology
MCHP
$39.6B
| $148K | 0.01% |
1,767
| – | – |
|
309
Ingredion
INGR
$6.6B
| $148K | 0.01% |
1,450
-12
| -0.8% | -$1.2K |
|
310
iShares ESG Aware MSCI EM ETF
ESGE
$6.9B
| $147K | 0.01% |
4,678
+73
| +2% | +$2.31K |
|
311
McCormick & Company Non-Voting
MKC
$14.9B
| $146K | 0.01% |
1,749
-40
| -2% | -$3.05K |
|
312
iShares US Medical Devices ETF
IHI
$3.41B
| $144K | 0.01% |
2,676
| – | – |
|
313
L3Harris
LHX
$48.9B
| $144K | 0.01% |
736
-226
| -23% | -$46.2K |
|
314
Avery Dennison
AVY
$13.5B
| $143K | 0.01% |
801
+78
| +11% | +$14.2K |
|
315
Motorola Solutions
MSI
$80.4B
| $143K | 0.01% |
500
| – | – |
|
316
Trane Technologies
TT
$98.8B
| $143K | 0.01% |
776
-29
| -4% | -$5.26K |
|
317
GE HealthCare
GEHC
$32.4B
| $143K | 0.01% |
+1,740
| New | +$124K |
|
318
Vertex Pharmaceuticals
VRTX
$137B
| $138K | 0.01% |
439
| – | – |
|
319
Edwards Lifesciences
EW
$52B
| $138K | 0.01% |
1,665
-608
| -27% | -$47.8K |
|
320
Fastenal
FAST
$57.1B
| $136K | 0.01% |
5,042
+1,010
| +25% | +$25.9K |
|
321
AMN Healthcare
AMN
$1.34B
| $136K | 0.01% |
1,638
-107
| -6% | -$10.1K |
|
322
Vishay Intertechnology
VSH
$4.69B
| $136K | 0.01% |
6,000
| – | – |
|
|
AKRO
323
DELISTED
Akero Therapeutics
AKRO
| $134K | 0.01% |
3,500
| – | – |
|
324
Newmont
NEM
$135B
| $133K | 0.01% |
2,717
| – | – |
|
325
Parker-Hannifin
PH
$125B
| $130K | 0.01% |
386
-5
| -1% | -$1.66K |
|
Similar funds
ZCM
CQS
WSTAM
CW
SCM
AFIMH
ICG
DA
Cambridge Trust's Q1 2023 Portfolio in Review
As of Q1 2023, Cambridge Trust held 831 positions worth $2.1B, down 6.2% from $2.24B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Cambridge Trust withdrew a net $212M in Q1 2023, closing 71 positions and reducing 304 holdings. Its most notable exit was Linde, an estimated $47.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cambridge Trust opened a new position in State Street SPDR S&P 600 Small Cap Value ETF worth $343K.
- Cambridge Trust's largest Q1 2023 buy was State Street SPDR S&P 600 Small Cap Value ETF: 4,500 shares worth $343K.
- Cambridge Trust added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $5.28M increase.
- Cambridge Trust's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $31.8M.
- Cambridge Trust fully exited Linde in Q1 2023, selling an estimated $47.4M.
- Cambridge Trust's ten largest holdings make up 29% of its $2.1B portfolio in Q1 2023.
- Cambridge Trust opened 19 new positions and closed 71 in Q1 2023.
- Cambridge Trust's portfolio value fell 6.2% quarter-over-quarter to $2.1B.
Based on Cambridge Trust's 13F filing for Q1 2023, filed 12 May 2023.